Evotec SE company logo
Evotec SE logo

Evotec SE (EVO)

Profile

Company profile for Evotec SE (EVO)
MetricValue
Full NameEvotec SE
TickerNASDAQ: EVO
ExchangeNASDAQ
SectorHealthcare
IndustrySpecialty & Generic Drug Manufacturers
CountryGermany
IPO
IndexesNot included
Websiteevotec.com
Employees4,766

Key Metrics

Evotec SE Key Details
MetricDateValue
Price$3.63
Price, 1D Change+8.36%
Market Cap$1B
-
PE Ratio-
Beta0.71
Revenue$862M
Revenue, 1Y Change+2.04%
EPS-$0.60
EPS, 1Y Change-133.27%

Chart

Add series to chart(max: 6)
Series
SUGGESTED SERIES
Evotec SE chart

Events

Evotec SE Events
MetricDateValue
Next EarningsN/A
Last Qtr. Earnings
Last Ann. Earnings
Last Ex-DividendN/AN/A
Next Ex-DividendN/AN/A
Last Split4:1
Next SplitN/AN/A
Last Ticker ChangeEVTC
Next Ticker ChangeN/AN/A

🔒 Log In To Unlock Full Data

Estimates

EVO Estimates
MetricDateValue
EPS-$0.60
EPS EstimateN/A-$0.66
EPS Est. ChangeN/A-10.90%
Revenue$862.07M
Revenue EstimateN/A$781.18M
Revenue Est. ChangeN/A-9.38%
Current Price$3.63
Price Target--
Price Tgt. Change--

🔒 Log In To Unlock Full Data

EPS

EVO EPS reported versus estimate values
YearEstimateReportedSurprise / Exp.
-$0.35-$0.26+26.74%
-$0.90-$0.60+33.54%
-$0.66N/A-10.90%
-$0.36N/A+39.81%
EVO EPS reported versus estimate values chart

Revenue

EVO revenue reported versus estimate values chart
YearEstimateReportedSurprise / Exp.
$816.87M$844.81M+3.42%
$797.01M$862.07M+8.16%
$781.18MN/A-9.38%
$839.70MN/A-2.60%
EVO revenue reported versus estimate values chart

🔒 Log In To Unlock Full Data

Performance

EVO Performance
MetricDateValue
Price, 1Y-15.78%
Price, 3Y-57.39%
Market Cap, 1Y-15.68%
Market Cap, 3Y-57.20%
Revenue, 1Y+2.04%
Revenue, 3Y+18.01%
EPS, 1Y-133.27%
EPS, 3Y-178.48%

🔒 Log In To Unlock Full Data

Technical Indicators

EVO Technical Indicators
MetricDateValue
Current Price$3.63
SMA 200$3.70
SMA 200 vs Price+1.89%
SMA 50$3.24
SMA 50 vs Price-10.75%
Beta0.71
ATR$0.12
14-Day RSI71.79
10-Day Volatility51.69%
1-Year Volatility55.12%

Dividends

EVO Dividends
MetricDateValue
N/A-
UpcomingN/AN/A
-
-
Dividends Paid$0.00
Payout Ratio0.00%

🔒 Log In To Unlock Full Data

Income & Profitability

EVO Income & Profitability
MetricDateValue
Revenue$862.07M
EPS-$0.60
Gross Profit$71.24M
Gross Margin8.26%
Operating Profit-$185.01M
Operating Margin-21.46%
Net Income-$212.10M
Net Margin-24.60%
EBITDA-$75.09M

🔒 Log In To Unlock Full Data

Financial Health

EVO Financial Health
MetricDateValue
Debt To Equity0.47
Current Ratio1.98
Quick Ratio1.89
-
F-Score4
Altman Z-Score0.57

Valuations

EVO Valuations
MetricDateValue
PE Ratio-
PS Ratio1.55
PB Ratio1.37
EV/EBITDA-28.91
Enterprise ValueN/A-

Balance Sheet

EVO Balance Sheet
MetricDateValue
Book Value$986.34M
Cash & Equivalents$410.89M
Total Assets$2.07B
Current Assets$706.17M
Total Liabilities$1.08B
Current Liabilities$356.82M
Total Debt$459.28M
Short Term Debt$52.60M
Accounts Payable$88.84M

Expenses

EVO Expenses
MetricDateValue
Total Expenses$1.07B
Operating Expenses$256.25M
Cost Of Goods Sold$790.83M
SG&A$0.00
D&A$109.92M
Interest Expense$0.00
Income Tax-$48.42M

Cash Flow

EVO Cash Flow
MetricDateValue
CFO$19.41M
CFI-$83.11M
CFF-$168.20M
Capex$143.04M
Free Cash Flow-$123.63M

Recent analyst updates

EVO Recent analyst updates
MetricDateValue
HC Wainwright & Co.
HC Wainwright & Co.
HC Wainwright & Co.
HC Wainwright & Co.
HC Wainwright & Co.
HC Wainwright & Co.
HC Wainwright & Co.
Morgan Stanley
B of A Securities
Citigroup

Analyst sentiment

Sentiment over the past month
EVO analyst sentiment distribution chart

Institutional ownership

Largest institutional holders by ownership percentage
EVO institutional ownership distribution chart

Screeners with EVO

Data Sources & References

  1. EVO Official Website www.evotec.com
  2. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1412558/000110465925035638/0001104659-25-035638-index.htm
  3. EVO Profile on Yahoo Finance finance.yahoo.com/quote/EVO
  4. EVO Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/evo

FAQ

  • What is the ticker symbol for Evotec SE?

    The ticker symbol for Evotec SE is NASDAQ:EVO

  • Does Evotec SE pay dividends?

    No, Evotec SE does not pay dividends

  • What sector is Evotec SE in?

    Evotec SE is in the Healthcare sector

  • What industry is Evotec SE in?

    Evotec SE is in the Specialty & Generic Drug Manufacturers industry

  • What country is Evotec SE based in?

    Evotec SE is headquartered in Germany

  • When did Evotec SE go public?

    Evotec SE initial public offering (IPO) was on February 5, 2004

  • Is Evotec SE in the S&P 500?

    No, Evotec SE is not included in the S&P 500 index

  • Is Evotec SE in the NASDAQ 100?

    No, Evotec SE is not included in the NASDAQ 100 index

  • Is Evotec SE in the Dow Jones?

    No, Evotec SE is not included in the Dow Jones index

  • When was Evotec SE last earnings report?

    Evotec SE's most recent earnings report was on August 14, 2025

  • When does Evotec SE report earnings?

    The date for Evotec SE's next earnings report has not been announced yet